The objectives of The Maastricht Study are to provide in-depth information on determinants of the development and progression of: 

  1. type 2 diabetes;
  2. its classic complications: cardiovascular disease, retinopathy, neuropathy and nephropathy; and
  3. its emerging comorbidities, such as cognitive decline, depression, and gastrointestinal, musculoskeletal and respiratory diseases.

The Maastricht Study will specifically focus on possible mechanisms that may explain why type 2 diabetes accelerates the development and progression of classic complications and emerging comorbidities. The study will also examine the above in relation to quality of life and the use of health care resources.

Sluit de enquête